Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials.

求助中 10 由 Michael 发布于 2026/11/9 17:20:34

DOI:10.1038/s41591-026-04739-2
作者：Khaled Ezzedine,?Harvey Lui,?Viktoria Eleftheriadou,?Seemal R Desai,?Thierry Passeron,?Julien Ringuet,?Nanja van Geel,?Albert Wolkerstorfer,?Charles Lynde,?Matthias Augustin,?José Luis López-Estebar
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：There is an unmet need for repigmentation therapies for patients with nonsegmental vitiligo (NSV) who are candidates for systemic therapy. Here, 52-week primary results are reported from two

应助信息

等您来应助

上传文件

42分钟前

Book学术机器人

2026/11/9 17:20:35 未找到该文献，机器人已退出，请等待人工下载

2026/11/9 17:20:34 Book学术AI机器人收到请求，开始寻找文献

2026/11/9 17:20:34 已向机器人发送请求

42分钟前

Michael 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAssociation between nighttime heart rate and cardiovascular mortality in patients with implantable cardioverter-defibrillator: A cohort study